testosteroneinwomen

Symptom quiz · Articles · Contact

Testosterone

Low Sex Drive in Perimenopause: Testosterone, Desire, and What Actually Helps

Annette Thompson · 14 min read · 2026-08-08

Low sex drive in perimenopause has a physiology behind it. What happens to desire, where testosterone fits, and the options with evidence behind them.

Two figs, one halved to show its interior, on cream linen in raking morning light, an editorial still life standing in for desire in midlife.

Among women aged 20 to 49 who went through surgical menopause, 26% met the criteria for hypoactive sexual desire disorder, against 14% of premenopausal women the same age. Losing your ovaries overnight roughly doubles the rate. That comparison sits inside the ISSWSH clinical practice guideline, and it's one of the cleanest natural experiments in the field, because the thing that changed abruptly was ovarian hormone production, including testosterone.

Most women don't lose their ovaries. They lose the same hormones slowly, over the eight or ten years of perimenopause, and the effect arrives so gradually that it gets attributed to the marriage, the workload, the kids, or simply to being in your forties. Then it gets raised in a seven-minute appointment and handled with a sympathetic look.

I'm a medical technologist, not a physician. What I can do is lay out what the research actually shows about desire in midlife, where testosterone fits, where it doesn't, and what the options look like when you take them seriously. My own low libido was one of the reasons I started testosterone, and I'll tell you what changed and what didn't.


What libido is, biologically

Libido gets described as if it were a single dial. It behaves more like a balance between two systems: excitation, which makes sexual cues register as interesting, and inhibition, which makes them register as irrelevant or as one more demand. Hormones, sleep, stress, medications, pain, and how you feel about your partner all feed into both sides.

The desire itself comes in two flavors, and knowing which one you're missing changes the conversation. Spontaneous desire is wanting sex out of nowhere, with no trigger. Responsive desire is wanting it once things are already underway. Most women have more of the responsive kind, and that's true across the lifespan rather than something that breaks in midlife. What tends to disappear first in perimenopause is the spontaneous kind, which is why so many women describe it as "the thought just never crosses my mind anymore" rather than "I don't enjoy it."

That distinction matters because it's completely possible to enjoy sex, orgasm normally, love your partner, and still never think about it. What's changed in that situation is the desire system's output, and women get told for years that it must mean something about their marriage.

Where testosterone comes into it: androgen receptors are distributed throughout the brain, including the dopamine pathways that generate wanting. Testosterone supports dopamine signaling and cerebral blood flow, and desire is downstream of that machinery working. The urologist Kelly Casperson put it to an FDA panel in 2025 as libido improving because dopamine and blood flow in the brain improve, and that ordering is the useful part. The full brain-science version is here: what testosterone actually does to your brain.


Why desire drops in perimenopause specifically

Four separate things happen at once, and they compound.

Testosterone is already down. By around 40, a woman's testosterone is roughly half what it was in her early twenties, and it falls another quarter or so between the early forties and the late fifties. It declines with age rather than dropping at menopause, so there's no single event to point at and no moment when anyone thinks to test it.

Estradiol becomes erratic, then low. In perimenopause estradiol doesn't decline smoothly. It swings, sometimes to levels higher than your twenties and then to very low, which is why some months feel normal and others don't. Low estradiol also produces vaginal dryness and thinning, and sex that hurts is the fastest way to stop wanting it. That one has a direct fix (local vaginal estrogen, which is low-dose, safe for most women, and works), and it's worth ruling out before concluding anything about desire.

Sleep breaks. Night sweats and early waking are perimenopausal symptoms, and there is no hormone in the world that produces desire in a woman getting five broken hours a night.

SHBG can rise. Sex hormone binding globulin holds testosterone in circulation and keeps it away from your tissues. Oral estrogen, combined oral contraceptives, thyroid replacement and hyperthyroidism all raise it, so free testosterone falls while your total testosterone reads perfectly normal on paper. If you're on the pill and were told your levels are fine: birth control, SHBG, and why your free testosterone tells a different story.


The part where it isn't hormonal

I'd be doing you a disservice if I sent you to a hormone clinic without this section, because plenty of low desire in midlife is not a testosterone problem, and the guidelines are clear that modifiable causes get addressed first.

Antidepressants. SSRIs and SNRIs reduce libido and blunt orgasm in a large share of the people who take them, and it's dose-related. If your desire dropped within a couple of months of starting or increasing one, that's the first suspect. I've been on an antidepressant for 30 years, so I'm not telling you to stop taking yours. I'm telling you it belongs at the top of the list, and that switching agents is a real conversation to have.

Pain. Vaginal dryness, vulvar burning, pelvic floor tension. Bodies learn quickly, and desire for something that reliably hurts fades on schedule.

Sleep, thyroid, iron, and alcohol. Unglamorous, and each of them can flatten desire on its own. A thyroid panel and a ferritin level are cheap.

Everything happening in the rest of your life. Resentment, exhaustion, caregiving for parents and teenagers at the same time, a partner who has not touched a chore in a decade. Hormones don't override any of that, and testosterone won't make an unappealing situation appealing.

The formal diagnosis, hypoactive sexual desire disorder, requires that the loss of desire has lasted at least six months and that it bothers you. If you have no desire and you're not troubled by it, nothing here needs fixing, and no clinician should be telling you otherwise. Distress is the criterion, and it belongs to you and not to your partner.


What testosterone can and can't do for desire

Here's the state of the evidence, stated without the hedging that usually surrounds it.

Improving sexual desire in postmenopausal women is the single indication the 2019 Global Consensus Position Statement endorses, and eleven societies signed it. The meta-analysis of randomized trial data behind it, Islam and colleagues in the Lancet Diabetes and Endocrinology, found consistent benefit for sexual function from non-oral testosterone at physiologic doses. This is the best-evidenced use of testosterone in women, and it's the one that gets dismissed most often as vanity.

What that benefit looks like in a trial is measurable and modest: more desire, less distress about the lack of it, and more satisfying sexual events. It is not a transformation into a different person, and clinics that promise one are selling something.

Timing, from the ISSWSH guideline: distress starts dropping around week 4, average effect emerges at 6 to 8 weeks, peak effect on desire arrives around 12 weeks, and distress keeps improving for five or six months. If nothing has changed at six months, the guideline says stop and look elsewhere rather than raising the dose.

Two honest limits. Safety data from the pooled trials don't extend much past two years, so nobody can tell you about decade twenty. And blood levels don't predict response, so a woman with a low number may feel nothing and a woman with a mid-range number may improve substantially. Nobody can look at your labs and tell you whether this will work for you.

The dose is where this gets specific, and it has its own page: testosterone dosing for women, forms and timelines.


What worked, for me

My libido was one of three reasons I started testosterone. The other two were depression that my antidepressant wasn't reaching and a brain that felt like it was running at 80%.

What came back first wasn't arousal. It was the thought crossing my mind at all. That's the piece I'd want a woman to understand before she starts, because if you're expecting a switch that makes you feel eighteen, you'll conclude it isn't working. What I noticed was that sex re-entered the category of things I might want, alongside a lot of other things that had quietly left that category. Getting out of bed. Starting a business. Going to the gym without negotiating with myself first. It arrived as part of a general return of wanting rather than as a separate sexual effect, which matches the mechanism: dopamine pathways don't run a dedicated sex channel.

I'll also tell you what didn't work. The first form I tried, a transdermal cream prescribed at Newson Health in London, didn't absorb well enough to do anything, and follow-up bloods confirmed it. I felt nothing for months and could easily have concluded testosterone was useless for me. The dose reaching your bloodstream is the variable, and the only way to know is to test.

And my current dosing is not a model. I inject a combination product available over the counter in Mexico, at a schedule that puts me above the physiologic female range, which I've written about plainly on the dosing page. I made that trade knowingly for myself. A clinician starting you from scratch would begin somewhere very different, and should.


How to raise this with a doctor without being dismissed

The complaint "I have no sex drive" invites a shrug. These don't.

Bring the timeline. When it changed, how fast, and what else changed at the same time. A desire drop that tracks a cycle becoming irregular reads differently than one that started three weeks after an SSRI increase.

Say the word distress. The diagnostic criterion is that this bothers you. Saying "this bothers me and it has for over a year" moves the conversation from lifestyle to clinical.

Ask for specific labs, not a hormone panel. Total testosterone and SHBG, drawn in the morning. Ask whether the lab runs mass spectrometry, because standard immunoassays are unreliable at female concentrations and that is why your labs come back "normal".

Rule out the fixable things out loud. Ask about vaginal estrogen for dryness, about your antidepressant, about thyroid and ferritin. A clinician who sees you working through the differential treats you differently than one who thinks you came in asking for a hormone.

Take estrogen seriously first. For most perimenopausal women, getting estradiol right fixes the sleep, the night sweats and the dryness, and desire sometimes follows without anything else. Testosterone is typically added on top of an optimized regimen rather than as the opening move.

If you get nowhere, that's common and not your fault: who will prescribe testosterone to a woman covers what to look for in a specialist.


Questions I get asked

Is low libido in perimenopause normal? It's extremely common, which is not the same as something you have to accept. Common means you're not unusual. It doesn't mean untreatable.

Will testosterone increase my sex drive? For postmenopausal women with distressing low desire, the randomized evidence says yes on average, with a modest effect size. Averages don't tell you about you, and the guideline builds in a six-month decision point precisely because a meaningful number of women won't respond.

How do I increase libido during perimenopause without hormones? Fix sleep first, because nothing works underneath exhaustion. Treat vaginal dryness, since pain kills desire fast. Look hard at your antidepressant and your alcohol intake. Resistance training helps mood, sleep and body image, all of which feed desire. And responsive desire is real, so for many couples starting from physical closeness rather than waiting to feel spontaneous wanting works better than either partner expects.

Does menopause end your sex drive permanently? No. Desire changes across the transition and postmenopause, and plenty of women report their sex lives improving afterward once sleep, dryness and contraception anxiety stop being factors.

My doctor said my testosterone is normal. Now what? Two possibilities. Your total may be normal while your free testosterone is low, usually from high SHBG, so ask for SHBG and a calculated free level. Or the assay is imprecise at female concentrations, which is common enough to have its own page here. Either way, the guideline is explicit that no blood level diagnoses this and no level predicts who responds, so "your labs are normal" is not the end of the conversation.

Is this the same as low libido from stress or a bad relationship? It can look identical from the outside, which is why the guidelines put modifiable factors first. A useful self-test: if desire is absent with a partner you're happy with, in a week where you slept well and nothing is on fire, that points away from circumstance.


Losing desire in your forties is one of the most under-investigated complaints in women's medicine, and the reason isn't that the research doesn't exist. It's that the questions get asked in seven minutes and answered with reassurance. You're allowed to ask for more than reassurance.

I'm a medical technologist sharing my own story and my own reading of the research, not your clinician. Everything here belongs in a conversation with someone who can examine you and read your labs alongside it.


The other pillars on this site: testosterone dosing for women · perimenopause symptoms and irregular periods · menopause brain fog

Sources

Testosterone and sexual desire - Davis SR, Baber R, Panay N et al., J Clin Endocrinol Metab 2019, the Global Consensus Position Statement on the Use of Testosterone Therapy for Women, endorsed by eleven societies: hypoactive sexual desire disorder in postmenopausal women is the only evidence-based indication. - Islam RM, Bell RJ, Green S, Page MJ, Davis SR, Lancet Diabetes and Endocrinology 2019, the systematic review and meta-analysis of randomized trial data behind the consensus: benefit for sexual function, no adverse lipid effect from non-oral physiologic dosing, safety data limited to 24 months. - Parish SJ, Simon JA, Davis SR et al., Journal of Women's Health 2021, the ISSWSH Clinical Practice Guideline: source for the 26% versus 14% HSDD prevalence comparison in surgically menopausal women aged 20 to 49, the response timeline, the six-month decision point, the position that no blood level diagnoses HSDD or predicts response, and the instruction to address modifiable factors first.

The age-related decline - Zumoff B, Strain GW, Miller LK, Rosner W, J Clin Endocrinol Metab 1995: the source of the "about half by 40" figure, an expected 0.61 nmol/L at 40 against 1.3 nmol/L at 21, read off a fitted regression in 33 healthy cycling women. - Wang Y, Islam RM, Bond M, Davis SR, eBioMedicine 2025, the Australian Women's Midlife Years (AMY) study, 1,104 women aged 40 to 69 measured by mass spectrometry: median testosterone fell from 0.56 nmol/L at ages 40 to 44 to 0.42 nmol/L at 55 to 59, roughly a quarter, with a nadir at 58 to 59 and no effect of natural menopause itself.

Desire, mood and the wider symptom picture - Glynne S, Kamal A, Kamel AM, Reisel D, Newson L, Archives of Women's Mental Health 2024: 510 peri- and postmenopausal women on transdermal testosterone; the highest response rate of any symptom tracked was "loss of interest in most things" at 56%, above libido. Observational, no placebo arm. - A Meta-Ethnography of Women's Intimate and Sexual Experiences Across the Menopause Continuum, International Journal of Women's Health 2025: qualitative synthesis of how women describe changes to intimacy through the transition.

Effect sizes for SSRI-associated sexual dysfunction are described here in plain language rather than with a number, because the reported rates vary widely by drug, dose and how the question is asked, and I would rather say "common and dose-related" than attach a precise figure to a range that wide.

Not medical advice. I'm a medical technologist, not a physician. I read the primary research and explain the study design so you can weigh it yourself. Every decision about your own treatment belongs with a qualified clinician who knows your history.

Read the other articles or start the six-part email series.